Results 1 to 10 of about 919 (150)
Recurrent Vulvovaginal Candidiasis: An Immunological Perspective [PDF]
Microorganisms, 2020 Vulvovaginal candidiasis (VVC) is a widespread vaginal infection primarily caused by Candida albicans. VVC affects up to 75% of women of childbearing age once in their life, and up to 9% of women in different populations experience more than three ...
Diletta Rosati +4 more
doaj +8 more sources
Distinct host immune responses in recurrent vulvovaginal candidiasis and vulvovaginal candidiasis [PDF]
Frontiers in Immunology, 2022 Recurrent vulvovaginal candidiasis (RVVC) and vulvovaginal candidiasis (RVVC) are one of the most common gynecological infections, primarily caused by Candida species. Although risk factors of RVVC and VVC have been identified in many studies, antifungal
Gai Ge +6 more
doaj +6 more sources
Risk factors for recurrent vulvovaginal candidiasis [PDF]
Vojnosanitetski Pregled, 2010 Background/Aim. Recurrent vulvovaginal candidiasis is relatively frequent condition, and may have serious health consequences, like chronic vulvovaginal pain syndrome. The aim of our study was to determine possible risk factors for recurrent vulvovaginal
Janković Slobodan +13 more
doaj +7 more sources
Clinical challenges in diagnosis and treatment of recurrent vulvovaginal candidiasis
SAGE Open Medicine, 2022 Vulvovaginal candidiasis is a common infection associated most often with the overgrowth of the fungal species Candida albicans . Although most women will have at least one episode of vulvovaginal candidiasis in their lifetime, some will experience ...
Chemen M Neal, Mark G Martens
doaj +4 more sources
Treatment of Recurrent Vulvovaginal Candidiasis With Ibrexafungerp
Journal of Investigative Medicine High Impact Case Reports, 2022 Recurrent vulvovaginal candidiasis is a common disorder which causes significant morbidity among women worldwide, and treatment options are limited.
Leah M. Grant MD, Robert Orenstein DO
doaj +4 more sources
Oteseconazole: An Advance in Treatment of Recurrent Vulvovaginal Candidiasis
Future Microbiology, 2021 Recurrent vulvovaginal candidiasis (RVVC) has significant disease, financial and quality-of-life burdens, affects women from all strata of society worldwide, and lacks an approved therapeutic solution. Fluconazole emerged in 2004 as an antifungal for RVVC; it provides symptom control and has been accepted worldwide as a first-line treatment.
Jack D Sobel, Paul Nyirjesy
exaly +3 more sources
Perceived stress in women with recurrent vulvovaginal candidiasis
Journal of Psychosomatic Obstetrics and Gynaecology, 2007 Recurrent vulvovaginal candidiasis (RVVC) has become very common. The aim of this study was to evaluate if women with RVVC perceive more signs of chronic stress than healthy control subjects.Thirty-three women with RVVC and 28 healthy control subjects completed a questionnaire about perceived stress at work and in private life, and a health ...
Eva Rylander
exaly +3 more sources
Insights and advances in recurrent vulvovaginal candidiasis.
PLoS Pathogens, 2023 Javier San Juan Galán +2 more
doaj +3 more sources
Modern concepts of etiopathogenesis and approaches to the treatment of recurrent vulvovaginal candidiasis [PDF]
Vestnik Dermatologii i Venerologii, 2023 Vulvovaginal candidiasis is a widespread infection caused by Candida. The disease affects 7580% of women of reproductive age at least once during their lifetime, and 920% of them indicate the presence of three or more episodes of the disease during the ...
Margarita R. Rakhmatulina
doaj +1 more source
Immunopathogenesis of recurrent vulvovaginal candidiasis [PDF]
Clinical Microbiology Reviews, 1996 Recurrent vulvovaginal candidiasis (RVVC) is a prevalent opportunistic mucosal infection, caused predominantly by Candida albicans, which affects a significant number of otherwise healthy women of childbearing age. Since there are no known exogenous predisposing factors to explain the incidence of symptomatic vaginitis in most women with idiopathic ...
P L, Fidel, J D, Sobel
openaire +3 more sources